STOCK TITAN

Bone Biologics Stock Price, News & Analysis

bblgw NASDAQ

Company Description

Welcome to the overview page for Bone Biologics (bblgw), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
+54.09%
Performance 1 year

Financial Highlights

-$4.1M
Net Income (TTM)
-$4.1M
Operating Cash Flow
Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Bone Biologics (bblgw) currently stands at 489 shares, up 145.7% from the previous reporting period, representing 0.6% of the float. Over the past 12 months, short interest has increased by 389%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Bone Biologics (bblgw) currently stands at 2.0 days, down 32.8% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 47.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.1 to 1000.0 days.

Frequently Asked Questions

What is the current stock price of Bone Biologics (bblgw)?

The current stock price of Bone Biologics (bblgw) is $31 as of February 12, 2026.

What is the net income of Bone Biologics (bblgw)?

The trailing twelve months (TTM) net income of Bone Biologics (bblgw) is -$4.1M.

What is the earnings per share (EPS) of Bone Biologics (bblgw)?

The diluted earnings per share (EPS) of Bone Biologics (bblgw) is $-4.83 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Bone Biologics (bblgw)?

The operating cash flow of Bone Biologics (bblgw) is -$4.1M. Learn about cash flow.

What is the current ratio of Bone Biologics (bblgw)?

The current ratio of Bone Biologics (bblgw) is 10.22, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Bone Biologics (bblgw)?

The operating income of Bone Biologics (bblgw) is -$4.2M. Learn about operating income.